Rajat Rohatgi

Medical oncologist, Thoracic specialist

Assistant Professor of Biochemistry and of Medicine (Oncology)

Thoracic Cancer Program

Professional Education

  • Fellowship: Stanford University - CAPS (2008) CA
  • Residency: Stanford University - CAPS (2004) CA
  • Board Certification: Medical Oncology, American Board of Internal Medicine (2008)
  • Board Certification: Internal Medicine, American Board of Internal Medicine (2005)
  • Medical Education: Harvard Medical School (2002) MA
  • Fellowship, Stanford Hospital, Medical Oncology (2008)
  • Residency, Stanford Hospital, Internal Medicine (2004)
  • Ph.D., Harvard Medical School, Cell Biology (2002)
  • M.D., Harvard Medical School (2002)
  • A.B., Harvard University, Biochemical Sciences (1994)

Honors & Awards

  • NIH Director's New Innovator Award, NIH (2012)
  • Distinguished Scientist Award, Sontag Foundation (2010)
  • Basil O' Connor Starter Scholar Award, March of Dimes Foundation (2010-2012)
  • Stand Up To Cancer Innovation Research Grant, American Association for Cancer Research (2010-2013)
  • Martin D. Abeloff Scholar, V Foundation for Cancer Research (2009-2011)
  • Josephine Q. Berry Faculty Scholar in Cancer Research, Stanford University (2009)
  • Howard Temin Pathway to Independance Award (K99/R00), NCI/NIH (2007)
  • Young Investigator Award, American Society for Clinical Oncology (2007)
  • Fellowship Award, Damon Runyon Cancer Research Fund (2006)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.